Error: Could not add to watchlist. X
+ Watchlist

Arena Pharmaceuticals Inc

RN3:GR
Ticker Change
RN3:GR has changed to a new ticker symbol
EUR
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
0.00%
% Price Change
+0.11%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Arena Pharmaceuticals, Inc. is a biotechnology company that has developed a receptor-based screening assay using their own CART technology.
Address
6154 Nancy Ridge Drive
San Diego, CA 92121
United States
Phone
1-858-453-7200
  • Amit D Munshi
    President/CEO
  • Kevin R Lind
    Exec VP/CFO/Chief Acctg Ofcr
  • Vincent Aurentz "Vince"
    Exec VP/Chief Business Officer
  • Steven W Spector
    Exec VP/Secy/General Counsel
  • Preston S Klassen
    Exec VP:R&D/Chief Medical Ofcr
Show More